KCTV: Atrial Fibrillation and New Treatment
Atrial fibrillation, or a-fib, is the most common type of treated heart arrhythmia, and it is estimated that 12.1 million people in the United States will have a-fib in 2030. Untreated, a-fib significantly increases your risk of heart attack and stroke, yet many people with a-fib have never been diagnosed.
Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.
Recent News
News
TIME: 8 Things Doctors Want You to Know Before Your Colonoscopy
News
Health News You Can Us: New Treatment for Stroke Survivors
News
Media Coverage: Infectious Disease Physician Explains Low Risk to Public as Kansas Health Officials Monitor Hantavirus Exposures
News
FOX 4: FDA-Approved Treatment Improves Stroke Survivor’s Mobility
News
FOX 4: Infertility Awareness Week
News